EUS-guided oncolytic adenovirus implantation in patients of non-operative pancreatic cancer
- VernacularTitle:超声内镜引导基因重组人溶瘤腺病毒植入治疗晚期胰腺癌初步研究
- Author:
Qi ZHU
;
Kai XU
;
Hui FU
;
Zhiyuan WU
;
Yiping HE
;
Xi CHEN
;
Huifang XIONG
;
Lu XIA
;
Jihong TAN
;
Yaozong YUAN
;
Yunlin WU
- Publication Type:Journal Article
- Keywords:
Endoscopic ultrasonography;
Pancreatic cancer;
Oncolytic viruses;
Ultrasonography,interventional
- From:
Chinese Journal of Digestive Endoscopy
2008;25(7):341-346
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the safety and efficacy of oncolytic adenovirus (H101) implantation under EUS guidance combined with gemcitabine in patients of non-operative pancreatic cancer.Methods From May 2007 to December 2007,6 patients with non-operative pancreatic cancer were enrolled in the study.H101 were implanted into 3 sites of the tumor under EUS guidance.Gemcitabine Was siren systemicly on d2,d9 and d16 after implantation, and repeated 1 month later.Tumor size and perfusion were assessed by computed reconstruction and perfusion imaging.Changes of clinical indices,adverse effects and complications were also recorded.Results All patients completed the two periods of treatment as planned.Tumor size decreased in 5 cases(18.21%-38.65%),but without statistical difference (P=0.078).The area of liver metastasis Was found decreased in 1 ease.Perfusion imaging showed significant increase of mean transit time(P=0.049) and improvement in blood flow,blood volume and permeability surface at 2 weeks after the treatment. KPS increased in 2 patients and pain score decreased in 3 patients.Three patients died 2.5,2.5 and 3 months respectively after the procedure.while 3 other patients are still alive with the survival time of 3,5 and 10 months. Major adverse effects associated with H101 implantation were fever and flu-like symptoms.Mild acute pancreatitis occurred in 1 cage.Conclusion EUS guided oncolytic adenovirus implantation in advanced pancreatic cancer is feasible and safe.With the combination of gemcitabine,it is capable of shrinking the tumor size,destroying the angiogenesis of the tumor and improving the patients'living quality.
